GR3020517T3 - Human erythropoietin muteins, their production and their use - Google Patents
Human erythropoietin muteins, their production and their useInfo
- Publication number
- GR3020517T3 GR3020517T3 GR960401877T GR960401877T GR3020517T3 GR 3020517 T3 GR3020517 T3 GR 3020517T3 GR 960401877 T GR960401877 T GR 960401877T GR 960401877 T GR960401877 T GR 960401877T GR 3020517 T3 GR3020517 T3 GR 3020517T3
- Authority
- GR
- Greece
- Prior art keywords
- production
- human erythropoietin
- muteins
- erythropoietin muteins
- epo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3923963A DE3923963A1 (de) | 1989-07-20 | 1989-07-20 | Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3020517T3 true GR3020517T3 (en) | 1996-10-31 |
Family
ID=6385421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960401877T GR3020517T3 (en) | 1989-07-20 | 1996-07-11 | Human erythropoietin muteins, their production and their use |
Country Status (13)
Country | Link |
---|---|
US (1) | US5457089A (el) |
EP (1) | EP0409113B1 (el) |
JP (1) | JP3062583B2 (el) |
KR (1) | KR0183981B1 (el) |
AT (1) | ATE139261T1 (el) |
AU (1) | AU638470B2 (el) |
CA (1) | CA2021528C (el) |
DE (2) | DE3923963A1 (el) |
DK (1) | DK0409113T3 (el) |
ES (1) | ES2090061T3 (el) |
GR (1) | GR3020517T3 (el) |
IE (1) | IE902643A1 (el) |
PT (1) | PT94761B (el) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100263845B1 (ko) * | 1989-10-13 | 2000-08-16 | 스튜어트 엘.왓트 | 에리트로포이에틴 동형체와 그의 제조방법 및 그를 포함하는제약학적 조성물 |
US7217689B1 (en) | 1989-10-13 | 2007-05-15 | Amgen Inc. | Glycosylation analogs of erythropoietin |
US5856298A (en) * | 1989-10-13 | 1999-01-05 | Amgen Inc. | Erythropoietin isoforms |
US6190864B1 (en) * | 1991-05-08 | 2001-02-20 | Chiron Corporation | HCV genomic sequences for diagnostics and therapeutics |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US5614184A (en) * | 1992-07-28 | 1997-03-25 | New England Deaconess Hospital | Recombinant human erythropoietin mutants and therapeutic methods employing them |
US6153407A (en) * | 1992-07-28 | 2000-11-28 | Beth Israel Deaconess Medical Center | Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics |
EP0667903A1 (en) * | 1992-07-28 | 1995-08-23 | New England Deaconess Hospital | Recombinant human erythropoietin with altered biological activity |
WO1994024160A2 (en) * | 1993-04-21 | 1994-10-27 | Brigham And Women's Hospital | Erythropoietin muteins with enhanced activity |
KR960701650A (ko) * | 1993-04-29 | 1996-03-28 | 찰스 엠. 브룩 | 에리트로포이에틴 유사체 조성물 및 방법(Eythropoietin analog compositions and methods) |
US5773569A (en) * | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5830851A (en) * | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
ES2333425T5 (es) | 1995-06-15 | 2012-08-28 | Crucell Holland B.V. | Sistemas de empaquetado para adenovirus recombinante humano destinados a terapia génica |
US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
ES2208798T3 (es) * | 1997-09-01 | 2004-06-16 | Aventis Pharma Deutschland Gmbh | Eritropoyetina humana recombinante con un perfil de glicosilacion ventajoso. |
US6506595B2 (en) * | 1998-03-31 | 2003-01-14 | Itoham Foods Inc. | DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs |
US6696411B1 (en) | 1998-04-22 | 2004-02-24 | Cornell Research Foundation, Inc. | Canine erythropoietin gene and recombinant protein |
WO1999054486A1 (en) | 1998-04-22 | 1999-10-28 | Cornell Research Foundation, Inc. | Canine erythropoietin gene and recombinant protein |
US7304150B1 (en) | 1998-10-23 | 2007-12-04 | Amgen Inc. | Methods and compositions for the prevention and treatment of anemia |
US7410941B1 (en) | 1999-04-13 | 2008-08-12 | The Kenneth S. Warren Institute, Inc. | Methods for treatment of neurodegenerative conditions by peripherally administered erythropoietin |
US7345019B1 (en) | 1999-04-13 | 2008-03-18 | The Kenneth S. Warren Institute, Inc. | Modulation of excitable tissue function by peripherally administered erythropoietin |
US8236561B2 (en) * | 1999-04-15 | 2012-08-07 | Crucell Holland B.V. | Efficient production of IgA in recombinant mammalian cells |
US7604960B2 (en) * | 1999-04-15 | 2009-10-20 | Crucell Holland B.V. | Transient protein expression methods |
US6855544B1 (en) | 1999-04-15 | 2005-02-15 | Crucell Holland B.V. | Recombinant protein production in a human cell |
US20050164386A1 (en) * | 1999-04-15 | 2005-07-28 | Uytdehaag Alphonsus G. | Overexpression of enzymes involved in post-translational protein modifications in human cells |
US7297680B2 (en) * | 1999-04-15 | 2007-11-20 | Crucell Holland B.V. | Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content |
US20050170463A1 (en) * | 1999-04-15 | 2005-08-04 | Abraham Bout | Recombinant protein production in permanent amniocytic cells that comprise nucleic acid encoding adenovirus E1A and E1B proteins |
CN100338091C (zh) * | 1999-09-25 | 2007-09-19 | 伊藤火腿株式会社 | 编码新的融合蛋白的dna和通过该dna的表达来制备有用的多肽的方法 |
US6703480B1 (en) | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
US7527961B2 (en) * | 1999-11-26 | 2009-05-05 | Crucell Holland B.V. | Production of vaccines |
US7192759B1 (en) | 1999-11-26 | 2007-03-20 | Crucell Holland B.V. | Production of vaccines |
AU7338501A (en) * | 2000-09-08 | 2002-03-22 | Gryphon Sciences | Polymer-modified synthetic proteins |
US7118737B2 (en) * | 2000-09-08 | 2006-10-10 | Amylin Pharmaceuticals, Inc. | Polymer-modified synthetic proteins |
EP1326969B1 (en) | 2000-09-25 | 2009-04-15 | Genetronics, Inc. | Improved system for regulation of transgene expression |
PA8536201A1 (es) | 2000-12-29 | 2002-08-29 | Kenneth S Warren Inst Inc | Protección y mejoramiento de células, tejidos y órganos que responden a la eritropoyetina |
US6531121B2 (en) | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US7767643B2 (en) * | 2000-12-29 | 2010-08-03 | The Kenneth S. Warren Institute, Inc. | Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
US6930086B2 (en) | 2001-09-25 | 2005-08-16 | Hoffmann-La Roche Inc. | Diglycosylated erythropoietin |
PT1465987E (pt) * | 2001-12-07 | 2008-04-15 | Crucell Holland Bv | Produção de vírus, isolados virais e vacinas |
WO2004003176A2 (en) * | 2002-07-01 | 2004-01-08 | The Kenneth S. Warren Institute, Inc. | Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs |
EP1539960B1 (en) | 2002-09-09 | 2010-04-28 | Hanall Pharmaceutical Co., Ltd. | Protease-resistant modified interferon alpha polypeptides |
CN100383238C (zh) | 2003-05-09 | 2008-04-23 | 克鲁塞尔荷兰公司 | E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法 |
DE602004027483D1 (de) * | 2003-05-23 | 2010-07-15 | Crucell Holland Bv | Herstellung von rekombinanten igm in den per.c6 zellen |
KR100632985B1 (ko) * | 2003-07-26 | 2006-10-11 | 메덱스젠 주식회사 | 생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들 |
CN1897959A (zh) * | 2003-09-29 | 2007-01-17 | 沃伦药品公司 | 用于治疗和预防脓毒病和粘连形成的组织保护细胞因子 |
WO2005037304A1 (en) * | 2003-10-17 | 2005-04-28 | Crucell Holland B.V. | Treatment and prevention of decubitus |
US7588745B2 (en) * | 2004-04-13 | 2009-09-15 | Si Options, Llc | Silicon-containing products |
AU2005235794A1 (en) * | 2004-04-23 | 2005-11-03 | Cambridge Antibody Technology Limited | Erythropoietin protein variants |
AR053416A1 (es) | 2005-11-10 | 2007-05-09 | Protech Pharma S A | Combinacion de glicoisoformas para el tratamiento o prevencion de la septicemia, linea celular transgenica productora de glicoformas de eritropoyetina, composicion farmaceutica que comprende a dicha combinacion, procedimientos para obtener la linea celular, procedimiento para producir dicha combinac |
AU2006316450A1 (en) * | 2005-11-24 | 2007-05-31 | Merck Serono Sa | Erythropoietin polypeptides and uses thereof |
JP2010510794A (ja) | 2006-11-28 | 2010-04-08 | ハナル ファーマシューティカル カンパニー リミテッド | 修飾型エリスロポエチンポリペプチド及びこの治療用用途 |
KR100700039B1 (ko) * | 2007-01-31 | 2007-03-26 | 이수왕 | 음료용 병 |
CA2712606A1 (en) | 2008-02-08 | 2009-08-13 | Ambrx, Inc. | Modified leptin polypeptides and their uses |
EP2334699B1 (en) | 2008-09-23 | 2013-09-11 | F. Hoffmann-La Roche AG | Purification of erythropoietin |
UA106731C2 (uk) | 2008-09-26 | 2014-10-10 | Амбркс, Інк. | Модифіковані поліпептиди еритропоетину тварин та їх застосування |
WO2022159414A1 (en) | 2021-01-22 | 2022-07-28 | University Of Rochester | Erythropoietin for gastroinfestinal dysfunction |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
US4835260A (en) * | 1987-03-20 | 1989-05-30 | Genetics Institute, Inc. | Erythropoietin composition |
-
1989
- 1989-07-20 DE DE3923963A patent/DE3923963A1/de not_active Withdrawn
-
1990
- 1990-07-14 ES ES90113505T patent/ES2090061T3/es not_active Expired - Lifetime
- 1990-07-14 AT AT90113505T patent/ATE139261T1/de not_active IP Right Cessation
- 1990-07-14 DE DE59010367T patent/DE59010367D1/de not_active Expired - Lifetime
- 1990-07-14 EP EP90113505A patent/EP0409113B1/de not_active Expired - Lifetime
- 1990-07-14 DK DK90113505.3T patent/DK0409113T3/da active
- 1990-07-19 PT PT94761A patent/PT94761B/pt not_active IP Right Cessation
- 1990-07-19 CA CA002021528A patent/CA2021528C/en not_active Expired - Lifetime
- 1990-07-19 IE IE264390A patent/IE902643A1/en not_active IP Right Cessation
- 1990-07-19 AU AU59145/90A patent/AU638470B2/en not_active Expired
- 1990-07-20 KR KR1019900011049A patent/KR0183981B1/ko not_active IP Right Cessation
- 1990-07-20 JP JP2192823A patent/JP3062583B2/ja not_active Expired - Lifetime
-
1994
- 1994-07-06 US US08/272,375 patent/US5457089A/en not_active Expired - Lifetime
-
1996
- 1996-07-11 GR GR960401877T patent/GR3020517T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
CA2021528C (en) | 2001-09-11 |
IE902643A1 (en) | 1991-02-27 |
DK0409113T3 (da) | 1996-10-07 |
AU5914590A (en) | 1991-01-24 |
US5457089A (en) | 1995-10-10 |
AU638470B2 (en) | 1993-07-01 |
ES2090061T3 (es) | 1996-10-16 |
PT94761B (pt) | 1997-03-31 |
PT94761A (pt) | 1991-03-20 |
DE59010367D1 (de) | 1996-07-18 |
DE3923963A1 (de) | 1991-01-31 |
KR0183981B1 (ko) | 1999-04-01 |
EP0409113A1 (de) | 1991-01-23 |
JPH0372885A (ja) | 1991-03-28 |
KR910003102A (ko) | 1991-02-26 |
ATE139261T1 (de) | 1996-06-15 |
CA2021528A1 (en) | 1991-01-21 |
EP0409113B1 (de) | 1996-06-12 |
JP3062583B2 (ja) | 2000-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3020517T3 (en) | Human erythropoietin muteins, their production and their use | |
DE3884427D1 (de) | Polyquaternaere polysiloxan-polymere, deren herstellung und verwendung in kosmetischen zubereitungen. | |
DE69019550T2 (de) | Piperidin-Derivate, ihre Herstellung und ihre Verwendung. | |
GR852023B (el) | ||
DE69022595T2 (de) | Herstellung von kohlefaser-halbfabrikaten. | |
DE3777366D1 (de) | 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung. | |
DE3885534D1 (de) | Arylphosphorderivate, ihre Herstellung und Verwendung. | |
DE3882593D1 (de) | Polypeptid und dessen herstellung. | |
DE69008454T2 (de) | Nitrolsothiolderivate, ihre Herstellung und Verwendung. | |
DE3576361D1 (de) | Rekombinante dna, damit transformierter mikroorganismus, und verfahren zur herstellung von menschlicher cu-zn superoxiddismutase unter verwendung des transformierten mikroorganismus. | |
DE3889980D1 (de) | Reaktivfarbstoffe, deren Herstellung und Verwendung. | |
DE3681368D1 (de) | Polymere produkte, zusammensetzungen, deren herstellung und verwendung. | |
DE68919259D1 (de) | N-Phenylimide, ihre Herstellung und Verwendung. | |
DE3870764D1 (de) | Anilinophenylthioharnstoffe, -isothioharnstoffe und -carbodiimide, ihre herstellung und verwendung in der schaedlingsbekaempfung. | |
ATE45164T1 (de) | Steroido(3,2-c>-pyrazole, als antiandrogene und ihre herstellung. | |
DE3862766D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3872337D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE3868287D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DK145988A (da) | Genteknologisk fremstillet 140 kd-antigen af plasmodium falciparum og dettes anvendelse | |
DE3868104D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE69023331D1 (de) | Behandeltes hämoglobin und dessen herstellung. | |
DE3872161D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. | |
DE59009879D1 (de) | Reaktivfarbstoffe, deren Herstellung und Verwendung. | |
DE59003728D1 (de) | 4-Aryl-2-halogenimidazol-5-carbonsäureester, ihre Herstellung und Verwendung. | |
DE3865033D1 (de) | Reaktivfarbstoffe, deren herstellung und verwendung. |